141 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
BMRN BioMarin Pharmaceutical Inc. $98.11 $17.42B N/A
Article Searches
BioMarin's Vimizim Wins Nod in China for Rare Genetic Malady http://www.zacks.com/stock/news/425808/biomarins-vimizim-wins-nod-in-china-for-rare-genetic-malady?cid=CS-ZC-FT-425808 Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.
BioMarin Announces Data on Hemophilia Candidate, Shares Fall http://www.zacks.com/stock/news/421580/biomarin-announces-data-on-hemophilia-candidate-shares-fall?cid=CS-ZC-FT-421580 May 29, 2019 - BioMarin (BMRN) announces significant reduction in annual bleed rate in phase III study evaluating gene therapy, valoctocogene roxaparvovec, in hemophilia A patients. However, investors are skeptical.
Biotech Stock Roundup: AMGN's Nuevolution Buyout, CELG, INCY Drugs' Label Expansion http://www.zacks.com/stock/news/421467/biotech-stock-roundup-amgns-nuevolution-buyout-celg-incy-drugs-label-expansion?cid=CS-ZC-FT-421467 May 29, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
3 Big Biotech Stocks That Warren Buffett Might Like https://www.fool.com/investing/2019/05/26/3-big-biotech-stocks-warren-buffett-might-like.aspx?source=iedfolrf0000001 May 26, 2019 - There's at least one thing about these biotechs that the Oracle of Omaha should find especially appealing.
BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaimé on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4257425-biomarin-pharmaceutical-inc-bmrn-ceo-j-j-bienaime-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare Apr 27, 2019 - BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2019 Results Conference Call April 25, 2019 04:30 PM ET Company Participants Traci McCarty - VP, IR J.J. Bienaimé - Chairman and CEO Hank Fuchs - Presiden
BioMarin (BMRN) Shares Down Despite Q1 Earnings & Sales Beat http://www.zacks.com/stock/news/404553/biomarin-bmrn-shares-down-despite-q1-earnings-sales-beat?cid=CS-ZC-FT-404553 Apr 26, 2019 - BioMarin's (BMRN) earnings and revenues surpass estimates in the first quarter.
Biomarin Pharmaceutical Inc (BMRN) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/04/26/biomarin-pharmaceutical-inc-bmrn-q1-2019-earnings.aspx?source=iedfolrf0000001 Apr 26, 2019 - BMRN earnings call for the period ending March 31, 2019.
New Strong Sell Stocks for April 16th http://www.zacks.com/stock/news/382045/new-strong-sell-stocks-for-april-16th?cid=CS-ZC-FT-382045 Apr 16, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Does Sangamo Have the Best Gene Therapy Program Now? https://www.fool.com/investing/2019/04/03/does-sangamo-have-the-best-gene-therapy-program-no.aspx?source=iedfolrf0000001 Apr 03, 2019 - The grandaddy of gene-editing stocks recently provided an encouraging update, but it isn't the only experimental hemophilia therapy out there.
New Strong Sell Stocks for March 29th http://www.zacks.com/stock/news/367359/new-strong-sell-stocks-for-march-29th?cid=CS-ZC-FT-367359 Mar 29, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Pages: 123456...15

Page 1>